GlassScriptPhysician profile
Nancy Susan Lieb
NPI 1538179122
$2,235.32
in general payments reported to CMS, 2019-2025
30 companies · $508 in 2025
The $508 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $63.06 · 2021: $172 · 2022: $413 · 2023: $397 · 2024: $299 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $594.03 | 2019-2024 | |
| Pfizer INC. | $289.39 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $164.22 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $125.64 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $125.28 | 2022-2025 | |
| Hologic Sales and Service, LLC | $101.14 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Gynesonics, INC. | $98.91 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $86.45 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.56 | 2019-2025 | |
| Sage Therapeutics, LLC | $79.79 | 2024-2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $63.49 | 2022-2024 | Exparel |
| Vertical Pharmaceuticals, LLC | $57.36 | 2019 | |
| Allergan, INC. | $46.56 | 2019-2020 | |
| Exact Sciences Corporation | $33.23 | 2023-2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $30.77 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.75 | 2025 | Proclaim |
| Nalu Medical, INC. | $20.86 | 2025 | Nalu Neurostimulation System |
| Duchesnay USA Incorporated | $20.82 | 2019 | |
| Organon LLC | $20.75 | 2024 | |
| Integra Lifesciences Corporation | $20.39 | 2025 | Codman Hakim, Codman Certas, Cusa Clarity |
| Therapeuticsmd, INC. | $17.92 | 2022 | |
| Novo Nordisk INC | $16.63 | 2023 | Wegovy |
| Supernus Pharmaceuticals, INC. | $16.61 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $15.92 | 2019 | |
| Exeltis, USA INC. | $15.89 | 2024 | Slynd |
| Avion Pharmaceuticals | $14.88 | 2023 | Balcoltra |
| Amgen INC. | $14.79 | 2019 | |
| Minerva Surgical, INC | $14.25 | 2023 | |
| Medtronic, INC. | $13.79 | 2025 | Ligasure |
| Evofem Biosciences, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Lieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.